Arcadia Biosciences (RKDA) Tops Q4 EPS by $1.31

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of $0.90, $1.31 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $1.26 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal